Sarah A Mess, MD | |
10700 Charter Dr, Suite 330, Columbia, MD 21044-3629 | |
(410) 910-2350 | |
(410) 910-2348 |
Full Name | Sarah A Mess |
---|---|
Gender | Female |
Speciality | Plastic Surgery |
Location | 10700 Charter Dr, Columbia, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740281047 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | D0062216 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sarah A Mess, MD 10700 Charter Dr, Suite 330, Columbia, MD 21044-3629 Ph: (410) 910-2350 | Sarah A Mess, MD 10700 Charter Dr, Suite 330, Columbia, MD 21044-3629 Ph: (410) 910-2350 |
News Archive
The new total-body PET/CT scanner could revolutionize our understanding and treatment of disease through analysis of better imaging data from the whole body.
Streamlining the cell culture workflow in a range of application areas, Olympus' renowned optical expertise has given rise to the new CKX53 microscope including a novel inversion phase contrast (IVC) imaging technique
Researchers headed by Erwin Wagner, the Director of the BBVA Foundation-CNIO Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (CNIO), have deciphered how a stress-inducible gene regulator, AP-1, controls the survival of liver tumor-initiating cells. These results, published in the online edition of Nature Cell Biology, could provide new preventive strategies and identify potentially targetable molecules to prevent liver cancer.
Why one after another new malaria vaccine tests well in the laboratory but fails in field trials has frustrated legions of malaria researchers, and has been the main stumbling block to malaria eradication. Now, a research team from Germany has unraveled that puzzle and shown that the problem is all about the skin and how it controls the immune system. The implications are profound.
A gene essential to the production of pain-sensing neurons in humans has been identified by an international team of researchers co-led by the University of Cambridge. The discovery, reported today in the journal Nature Genetics, could have implications for the development of new methods of pain relief.
› Verified 4 days ago